Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigan for Apokyn-induced Nausea in Parkinson's Disease
NCT00489255Phase 4Completed
- Sponsor
- Ipsen
- Start
- May 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trimethobenzamide in nausea ((none)), Vomiting, sponsored by Ipsen. Started May 2007; status: completed.
02
Drugs
trimethobenzamide
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00489255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489255.